Our goal was to search for associations between BDNF, CRP, IL-6 and clinical symptoms, cognitive and personal performance in patients with paranoid schizophrenia to try to identify specific subtypes of patients and search for their potential therapeutic targets. The gene discussed is BDNF; the disease is schizophrenia.